| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Apr 08, 2024 | Sale | $11.10 | 3,435 | 38,129 | 95,263 | Apr 10, 2024, 04:30 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Jan 19, 2024 | Sale | $7.75 | 6,307 | 48,900 | 98,698 | Jan 22, 2024, 08:22 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Nov 20, 2023 | Sale | $7.24 | 2,127 | 15,403 | 103,061 | Nov 21, 2023, 04:40 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Nov 01, 2023 | Sale | $8.88 | 12,492 | 110,871 | 116,869 | Nov 03, 2023, 04:55 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Jul 14, 2023 | Option Exercise | $1.00 | 25,000 | 25,000 | 95,180 | Jul 17, 2023, 05:00 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Jun 02, 2023 | Sale | $11.41 | 1,960 | 22,368 | 68,506 | Jun 05, 2023, 06:32 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | May 22, 2023 | Sale | $12.87 | 2,110 | 27,165 | 70,466 | May 23, 2023, 12:15 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Apr 06, 2023 | Sale | $7.27 | 3,439 | 25,002 | 72,576 | Apr 07, 2023, 03:18 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Mar 01, 2023 | Sale | $8.53 | 2,032 | 17,335 | 76,015 | Mar 03, 2023, 07:03 PM | |
| PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | CFO and CBO | Nov 21, 2022 | Sale | $9.60 | 2,159 | 20,726 | 43,341 | Nov 23, 2022, 04:10 PM | |
| URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Officer | Jan 31, 2022 | Sale | $7.58 | 331 | 2,509 | 5,248 | Feb 02, 2022, 04:34 PM | |
| URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Officer | Nov 30, 2021 | Sale | $12.03 | 2,587 | 31,122 | 4,913 | Dec 02, 2021, 01:15 PM | |
| URGN | UroGen Pharma Ltd. | Henderson Molly | Chief Financial Officer | May 17, 2021 | Buy | $15.85 | 2,500 | 39,625 | 2,500 | May 18, 2021, 11:36 AM | |
| ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice President & CFO | Apr 11, 2019 | Option Exercise | $3.68 | 2,500 | 9,200 | 5,833 | Apr 11, 2019, 12:11 PM | |
| ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice President & CFO | Apr 09, 2019 | Option Exercise | $3.86 | 3,000 | 11,579 | 2,900 | Apr 10, 2019, 09:12 AM | |
| ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice President & CFO | Jun 12, 2018 | Option Exercise | $1.89 | 5,000 | 9,450 | 5,000 | Jun 13, 2018, 06:37 PM | |
| VSCP | VirtualScopics, Inc. | Henderson Molly | CBFO | Jun 19, 2012 | Buy | $0.90 | 8,000 | 7,200 | 14,400 | Jun 21, 2012, 04:46 PM |
Menu